Risk factors for cardiovascular disease in patients with metabolic-associated fatty liver disease: a machine learning approach

Karolina Drożdż; Katarzyna Nabrdalik; Hanna Kwiendacz; Mirela Hendel; Anna Olejarz; Andrzej Tomasik; Wojciech Bartman; Jakub Nalepa; Janusz Gumprecht; Professor Gregory Lip

doi:10.1186/s12933-022-01672-9

Related publications

Article2024

Machine Learning Identifies Metabolic Dysfunction–Associated Steatotic Liver Disease in Patients With Diabetes Mellitus

Katarzyna Nabrdalik, Hanna Kwiendacz, Krzysztof Irlik, Mirela Hendel, Karolina Drożdż, Agata M. Wijata, Jakub Nalepa, Oliwia Janota, Wiktoria Wójcik, Janusz Gumprecht, Professor Gregory Lip

Article2021

Metabolic-Associated Fatty Liver Disease (MAFLD), Diabetes, and Cardiovascular Disease: Associations with Fructose Metabolism and Gut Microbiota

Karolina Drożdż, Katarzyna Nabrdalik, Weronika Hajzler, Hanna Kwiendacz, Janusz Gumprecht, Professor Gregory Lip

Article2023

Machine learning profiles of cardiovascular risk in patients with diabetes mellitus: the Silesia Diabetes-Heart Project

Hanna Kwiendacz, Agata M. Wijata, Jakub Nalepa, Julia Piaśnik, Justyna Kulpa, Mikołaj Herba, Sylwia Boczek, Kamil Kegler, Mirela Hendel, Krzysztof Irlik, Janusz Gumprecht, Professor Gregory Lip, Katarzyna Nabrdalik

Article2023

Machine Learning Predicts Cardiovascular Events in Patients With Diabetes: The Silesia Diabetes-Heart Project

Katarzyna Nabrdalik, Hanna Kwiendacz, Karolina Drożdż, Krzysztof Irlik, Mirela Hendel, Agata M. Wijata, Jakub Nalepa, Elon Correa, Weronika Hajzler, Oliwia Janota, Wiktoria Wójcik, Janusz Gumprecht, Professor Gregory Lip

Article2024

The influence of perilipin 5 deficiency on gut microbiome profiles in murine metabolic dysfunction-associated fatty liver disease (MAFLD) and MAFLD-hepatocellular carcinoma

Marinela Krizanac, Paula Štancl, Paola Berenice Mass Sanchez, Rosa Karlić, Diana Moeckel, Twan Lammers, Anastasia Asimakopoulos, Ralf Weiskirchen

Risk factors for cardiovascular disease in patients with metabolic-associated fatty liver disease: a machine learning approach

Abstract

Discussion(0)